e-learning
resources
Munich 2014
Sunday, 07.09.2014
Sadoul Lecture “From molecules and cells to phenotypes: deciphering chronic airways disease” followed by related presentations
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Translational strategy for allergic asthma
M. Benson (Linkoping, Sweden)
Source:
International Congress 2014 – Sadoul Lecture “From molecules and cells to phenotypes: deciphering chronic airways disease” followed by related presentations
Session:
Sadoul Lecture “From molecules and cells to phenotypes: deciphering chronic airways disease” followed by related presentations
Session type:
Sadoul Lecture
Number:
367
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Benson (Linkoping, Sweden). Translational strategy for allergic asthma. International Congress 2014 – Sadoul Lecture “From molecules and cells to phenotypes: deciphering chronic airways disease” followed by related presentations
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
Specific immunotherapy in the management of allergic asthma
Source: Annual Congress 2008 - PG2 - Asthma: natural history, risk factors and overall management
Year: 2008
Therapeutic approach in allergic asthma: ASIT oposit to ICS
Source: Annual Congress 2010 - Clinical aspects and treatment of asthma and allergic respiratory diseases
Year: 2010
Translational models in asthma and COPD
Source: International Congress 2016 – Closing the gap: novel translational research strategies
Year: 2016
Immunotherapy prevents the development of asthma in subjects with allergic rhinitis
Source: Eur Respir J 2001; 18: Suppl. 33, 482s
Year: 2001
Evaluation of six-year allergen immunotherapy in allergic rhinitis and allergic asthma
Source: Eur Respir J 2006; 28: Suppl. 50, 439s
Year: 2006
Specific allergen immunotherapy of asthma combined with allergic rhinitis
Source: Eur Respir J 2006; 28: Suppl. 50, 441s
Year: 2006
Allergic asthma: determinants of asthma control
Source: Annual Congress 2008 - Risk factors for asthma versus asthma control
Year: 2008
Utility of Interleukin-5 in phenotyping allergic versus non allergic asthma
Source: Virtual Congress 2021 – Advances in asthma treatment: monoclonal antibodies
Year: 2021
Development of an integrated allergic rhinitis and asthma model with partial immunological tolerance
Source: Annual Congress 2009 - Animal models of airways inflammation
Year: 2009
Genetics and epigenetics of hyperresponsiveness in asthma and full asthma remission
Source: International Congress 2017 – Sadoul Lecture: "Airway hyperresponsiveness: the riddle of asthma and COPD" and related topics
Year: 2017
Rhinophototherapy: a new tool for the treatment of allergic rhinitis?
Source: ISSN=ISSN 1810-6838, ISBN=, page=174
Year: 2005
Impact of allergic rhinitis on asthma
Source: Annual Congress 2012 - PG6 Hot topics in paediatric allergy
Year: 2012
Should patients with mild asthma be excluded from allergic rhinitis drug trials?
Source: International Congress 2015 – Immune mechanisms in the human lung
Year: 2015
Establishing an asthma cutpoint for the ´Control of allergic rhinitis and asthma test´ using an international survey
Source: International Congress 2018 – Primary care management of asthma
Year: 2018
Combined therapy of asthma and allergic rhinitis
Source: Annual Congress 2013 –Treatment of asthma
Year: 2013
Treatment of co-morbid allergic asthma and perennial allergic rhinitis with the anti-IgE agent omalizumab
Source: Eur Respir J 2003; 22: Suppl. 45, 203s
Year: 2003
Anti-IgE treatment: An alternative for severe allergic occupational asthma
Source: Annual Congress 2012 - Asthma and COPD at work: what are the effects of exposure and risk factors?
Year: 2012
Small airways dysfunction: the link between allergic rhinitis and allergic asthma
Source: Eur Respir J, 51 (2) 1701749; 10.1183/13993003.01749-2017
Year: 2018
Omalizumab is equally effective in persistent allergic oral corticosteroid-dependent asthma whether due to seasonal allergens or to perennial allergens
Source: International Congress 2015 – Asthma and lung immunology
Year: 2015
Prognosis of allergic and non-allergic asthma
Source: Annual Congress 2012 - Mechanisms and modulation of allergic inflammation in the lung
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept